This pandemic has been much worse for the elderly, who have borne the overwhelming brunt of the deaths. But one sector that leans heavily on pensioner pounds is doing noticeably well this year – pharmaceuticals, and it not just because of Covid. Share prices of many British pharmaceutical firms have grown strongly despite a stock … Read more
MARKET REPORT: Pharma giants Astrazeneca and Glaxosmithkline boosted as Covid-19 vaccine hopes grow By Francesca Washtell For The Daily Mail Published: 21:50 BST, 7 September 2020 | Updated: 22:15 BST, 7 September 2020 Markets started the week on the front foot as pharmaceuticals firms large and small made strides in the battle to beat Covid-19. … Read more
MARKET REPORT: In the battle to beat coronavirus, London-listed companies both large and small punch well above their weight By Francesca Washtell For The Daily Mail Published: 22:19 BST, 27 August 2020 | Updated: 22:21 BST, 27 August 2020 In the battle to beat Covid-19, London-listed companies both large and small have punched well above … Read more
Verona Pharma became the latest biotechnology minnow to wow London investors with its work to help combat Covid-19. The AIM-listed group has been given permission by US authorities to test an inhaler containing its drug ensifentrine on hospitalised coronavirus patients in Alabama. It believes the chronic obstructive pulmonary disease (COPD) treatment could help reduce inflammation … Read more
Big Pharma spent nearly $250 MILLION to sway lawmakers amid the pandemic: Firms making coronavirus drugs and vaccines like Biogen and Novartis accounted for 25% of all lobbying spending in the first quarter of 2020 Researchers found the health sector spent $250million lobbying lawmakers from January 1 to March 31 of 2020 This accounts of … Read more
Pascal Soriot is on a mission. Not satisfied that in the midst of the coronavirus pandemic AstraZeneca has become Britain’s most valuable company, he believes that his scientists – together with those of Oxford University – are well on the way to producing the first proven vaccine against SARS-CoV-2, the virus behind the pandemic. Not … Read more
ALEX BRUMMER: Pharmaceutical analysts in overdrive at prospect of mega-merger between Astrazeneca and Gilead By Alex Brummer for the Daily Mail Published: 22:00 BST, 8 June 2020 | Updated: 22:00 BST, 8 June 2020 Nothing gets the blood running in the investment community like the prospect of a mega-merger. So the possibility of Astrazeneca and … Read more
As global efforts to tackle the pandemic intensify, so the spotlight has finally shifted to focus on the potential of small pharma players during the week beginning 27th April. According to Ivan Sedgwick, a director at corporate finance firm LGB & Co, the poor share price performance of major healthcare names has demoralised investors, forcing … Read more
Testing has always been key to battling coronavirus. But, now that governments are shifting their attention to easing lockdown restrictions, testing both for the active virus and the evidence someone has already had it are more important than ever. Two British pharmaceuticals groups shone on AIM yesterday on their testing-related milestones. Novacyt has inked a … Read more
Britain’s world class big pharma companies were always going to be a huge asset in the fight against Covid-19 and in finding solutions, not just to this pandemic, but to future similar events. We have now been offered insights into their thinking. Glaxosmithkline, where Emma Walmsley’s first years as chief executive were marked by some … Read more